NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 318 filers reported holding NATERA INC in Q3 2023. The put-call ratio across all filers is 1.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,489,557 | +50.7% | 33,665 | +65.7% | 0.00% | 0.0% |
| Q2 2023 | $988,165 | -9.3% | 20,312 | +3.5% | 0.00% | 0.0% |
| Q1 2023 | $1,088,946 | +84.1% | 19,616 | +33.4% | 0.00% | +100.0% |
| Q4 2022 | $591,526 | +4.0% | 14,700 | +13.4% | 0.00% | 0.0% |
| Q3 2022 | $569,000 | +94.2% | 12,960 | +56.6% | 0.00% | 0.0% |
| Q2 2022 | $293,000 | +2.1% | 8,274 | +17.0% | 0.00% | 0.0% |
| Q1 2022 | $287,000 | -88.4% | 7,069 | -73.3% | 0.00% | -80.0% |
| Q4 2021 | $2,473,000 | -26.7% | 26,490 | -12.6% | 0.01% | -28.6% |
| Q3 2021 | $3,376,000 | +21.3% | 30,293 | +23.6% | 0.01% | +16.7% |
| Q2 2021 | $2,784,000 | +31.0% | 24,515 | +17.1% | 0.01% | +20.0% |
| Q1 2021 | $2,126,000 | +39.4% | 20,937 | +36.6% | 0.01% | +25.0% |
| Q4 2020 | $1,525,000 | +12.5% | 15,325 | -20.2% | 0.00% | 0.0% |
| Q3 2020 | $1,355,000 | +111.1% | 19,206 | +49.1% | 0.00% | +100.0% |
| Q2 2020 | $642,000 | +844.1% | 12,880 | +334.7% | 0.00% | – |
| Q1 2020 | $68,000 | – | 2,963 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,104,581 | $48,403,000 | 19.54% |
| Kynam Capital Management, LP | 2,018,360 | $88,445,000 | 18.64% |
| Foresite Capital Management III, LLC | 159,160 | $6,974,000 | 18.41% |
| Sofinnova Investments, Inc. | 3,102,960 | $135,972,000 | 7.91% |
| Eagle Health Investments LP | 595,994 | $26,116,000 | 5.99% |
| Eversept Partners, LP | 1,425,602 | $62,469,880 | 5.41% |
| Lagoda Investment Management, L.P. | 159,220 | $6,977,000 | 4.96% |
| Hudson Executive Capital LP | 588,886 | $25,805,000 | 3.70% |
| Parian Global Management LP | 24,000 | $1,052,000 | 3.42% |
| BRANDYWINE MANAGERS, LLC | 21,534 | $944,000 | 3.10% |